Results 191 to 200 of about 21,850,323 (312)

Proceedings of the Global Health Focus Youth Conference 2025: The Role of Young People in Advancing Global Health Education, Research, and Leadership. [PDF]

open access: yesPublic Health Chall
Othman ZK   +9 more
europepmc   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Compassion and primary health care

open access: yes
iv, 19 p.This discussion paper explores the role of compassion as a foundational value and driving force within primary health care (PHC) and health systems strengthening.
World Health Organization
core  

Tuberculosis at a crossroads

open access: yesThe Lancet Global Health
The Lancet Global Health
doaj   +1 more source

Hantavirus infections: A growing global health concern. [PDF]

open access: yesWorld J Virol
Uppala PK   +3 more
europepmc   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Strengthening public health systems globally

open access: yes
Issue title: Strengthening public health systems globally.Welcome to the fourth quarter E-Brief, designed to inform readers about key global health activities at the Centers for Disease Control and Prevention (CDC).

core  

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy